Page last updated: 2024-10-29

ketoconazole and Actinic Reticuloid Syndrome

ketoconazole has been researched along with Actinic Reticuloid Syndrome in 3 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"Ketoconazole was administered for 27 to 70 days in a daily oral dose of 200 or 400 mg."1.26Oral ketoconazole. An effective and safe treatment for dermatophytosis. ( Artis, WM; Jones, HE; Simpson, JG, 1981)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jones, HE1
Simpson, JG1
Artis, WM1
Santucci, B1
Cristaudo, A1
Cannistraci, C1
Mohamed, KN1

Other Studies

3 other studies available for ketoconazole and Actinic Reticuloid Syndrome

ArticleYear
Oral ketoconazole. An effective and safe treatment for dermatophytosis.
    Archives of dermatology, 1981, Volume: 117, Issue:3

    Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Dermatomycoses; Female; Humans; Imidazoles; Ke

1981
[Results of an experimental study on skin tolerance and photo-biological activity of a product based on itraconazole].
    Annali dell'Istituto superiore di sanita, 1987, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Aged; Child; Dermatitis, Atopic; Dermatitis, Contact; Drug Eruptions; Drug Evalua

1987
Severe photodermatitis during ketoconazole therapy.
    Clinical and experimental dermatology, 1988, Volume: 13, Issue:1

    Topics: Adult; Female; Humans; Ketoconazole; Photosensitivity Disorders

1988